Related Articles by Review for PMID: 29939605

Year	Number of Results
1989	2
1991	1
1993	2
1995	2
1998	2
2001	1
2004	1
2005	2
2006	6
2007	8
2008	1
2010	4
2011	4
2012	4
2013	4
2014	3
2015	1
2016	5
2017	2
2018	2
2020	1
2021	1
2023	1
2024	2
2025	1

1

Reed M, Kerndt CC, Gopal S, Pellegrini MV, Nicolas D. Reed M, et al. 2024 Feb 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 29939605 Free Books & Documents.

2

Conventional and novel drug therapeutics to relief myocardial ischemia.

Dvir D, Battler A. Dvir D, et al. Cardiovasc Drugs Ther. 2010 Aug;24(4):319-23. doi: 10.1007/s10557-010-6254-8. Cardiovasc Drugs Ther. 2010. PMID: 20658184 Review.

3

Pharmacologic therapy of angina pectoris.

Zavecz JH, Bueno O. Zavecz JH, et al. J La State Med Soc. 1995 May;147(5):208-10, 213-6. J La State Med Soc. 1995. PMID: 7782675 Review.

4

[Conservative therapy of patients with stable coronary heart disease].

Custodis F, Laufs U. Custodis F, et al. Herz. 2012 Feb;37(1):85-96. doi: 10.1007/s00059-011-3578-5. Herz. 2012. PMID: 22331062 Review. German.

5

Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.

Rosano GMC, Vitale C, Volterrani M. Rosano GMC, et al. Cardiovasc Drugs Ther. 2016 Aug;30(4):393-398. doi: 10.1007/s10557-016-6674-1. Cardiovasc Drugs Ther. 2016. PMID: 27417323 Review.

6

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.

Thadani U. Thadani U. Expert Opin Pharmacother. 2012 Dec;13(17):2555-63. doi: 10.1517/14656566.2012.740458. Epub 2012 Nov 2. Expert Opin Pharmacother. 2012. PMID: 23121448 Review.

7

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Kones R. Kones R. Vasc Health Risk Manag. 2010 Sep 7;6:749-74. doi: 10.2147/vhrm.s11100. Vasc Health Risk Manag. 2010. PMID: 20859545 Free PMC article. Review.

8

Ranolazine: effects on ischemic heart.

Rognoni A, Barbieri L, Cavallino C, Bacchini S, Veia A, Degiovanni A, Rametta F, Nardi F, Lazzero M, Lupi A, Bongo AS. Rognoni A, et al. Recent Pat Cardiovasc Drug Discov. 2013 Dec;8(3):197-203. doi: 10.2174/15748901113089990023. Recent Pat Cardiovasc Drug Discov. 2013. PMID: 23961914 Review.

9

Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review.

Padala SK, Lavelle MP, Sidhu MS, Cabral KP, Morrone D, Boden WE, Toth PP. Padala SK, et al. J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):499-510. doi: 10.1177/1074248417698224. Epub 2017 Mar 31. J Cardiovasc Pharmacol Ther. 2017. PMID: 28361599 Review.

10

Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.

Mody P, Sidhu MS, Brilakis ES, Sacco JD, Banerjee S, Boden WE. Mody P, et al. Cardiol Rev. 2016 Jul-Aug;24(4):177-89. doi: 10.1097/CRD.0000000000000085. Cardiol Rev. 2016. PMID: 26274534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 29939605

60 results

Results by year